About this product
The blend combines 265 mg of Boswellia extract with luteolin, vitamin C, and L. acidophilus L-92. Its design is more relevant to seasonal immune-response support than to buyers seeking a pure joint formula.
The Boswellia amount approaches a useful extract range, but the label does not state total boswellic acids or AKBA. A dry capsule offers no lipid carrier or other delivery aid for the botanical ingredients.
One capsule per serving is convenient, yet the ongoing cost is high for the level of Boswellia disclosure. It best suits users who specifically want the combined ingredient concept and accept uncertainty around the bacterial ingredient amount expressed only by weight.
Pros
Combines four complementary ingredient types Boswellia amount is meaningful for a blend Convenient single-capsule serving
Cons
No boswellic-acid or AKBA percentage L-92 is listed by weight rather than viable count High ongoing cost for incomplete potency details
Warnings
Boswellia may add to anticoagulant or antiplatelet effects. The bacterial ingredient may not suit severely immunocompromised users without professional guidance. Vitamin C and Boswellia may cause digestive upset in sensitive users.